RUSVISK: DOMESTICALLY DEVELOPED PRODUCT OF HYALURONIC ACID: ASSESSMENT OF EFFICACY AND SAFETY IN EARLY STAGES OF THE KNEE OSTEOARTHRITIS
https://doi.org/10.14412/1995-4484-2014-538-544
Abstract
Objective: to compare the efficacy and safety of intra-articular therapy with Rusvisk (hyaluronic acid product) and Ostenil in early stages of knee osteoarthritis.
Subjects and methods. 50 patients with II–III stage of the knee osteoarthritis were included in the randomized double blinded controlled study. They had pain at movement of more than 40 mm by visual analogue scale (VAS) and Lequesne index of 4–12. All patients received a course of three intra-articular injections with products of hyaluronic acid at the interval of 7 days. Rusvisk (molecular weight 3500 kDa) was administered to 25 patients, whereas other 25 received Ostenil (molecular weight 1200–1400 kDa). In 1, 2, 3 weeks after the first injection following criteria were registered: changes of WOMAC index, pain at movement and at rest by VAS, general assessment of therapy efficacy by doctor and patient, assessment of efficacy according to OMERACTOARSI.
Results. In three weeks after the first injection a significant decrease of pain at movement (by 69% in Rusvisk group and by 55% in Ostenil group) and of WOMAC index (by 63% in Rusvsik group and by 60% in Ostenil group) was achieved in both groups without any differences between them. Significant decrease of pain at rest was observed at all visits only in Rusvisk group. When assessing the general efficacy, patients found more advantagesin the domestic product, whereas the therapist did not see the differences between groups. Response to the therapy by OMERACT-OARSI criteria was observed in 88% of patients in Rusvisk group and in 64% in Ostenil group. Short-term pain in the site of injection was mentioned by 64% of patients from Rusvisk group and by 72% from Ostenil group.
Conclusion. Intra-articular therapy with the products of hyaluronic acid «Rusvisk», «Ostenil» provides comparable decrease of pain and improvement of functional parameters in patients with knee osteoarthritis.
About the Authors
N. V. Vas'kova
Ural State Medicine University, Yekaterinburg, Russia
Russian Federation
Russian Federation
O. M. Lesnyak
Ural State Medicine University, Yekaterinburg, Russia
Russian Federation
Russian Federation
References
1. Peat G, McCarney R, Croft P. Knee pain and osteoarthritis in older adults: a review of community burden and current use of primary health care. Ann Rheum Dis. 2001;60(2):91–7. DOI: http://dx.doi.org/10.1136/ard.60.2.91.
2. Галушко ЕА, Большакова ТЮ, Виноградова ИБ и др. Структура ревматических заболеваний среди взрослого населения России по данным эпидемиологического исследования. Научно-практическая ревматология. 2009;(1):11–7. [Galushko EA, Bol'shakova TYu, Vinogradova IB, et al. Structure of rheumatic diseases among adult population of Russia according to data of an epidemiological study (preliminary results). Nauchno-prakticheskaya revmatologiya = Rheumatology Science and Practice. 2009;(1):11–7. (In Russ.)]. DOI: http://dx.doi.org/10.14412/1995-4484-2009-136.
3. Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Arthritis Rheum. 2000;43(9):1905–15. DOI: http://dx.doi.org/10.1002/1529-131(200009)43:9%3C1905::AID-ANR1%3E3.0.CO;2-P.
4. Moreland LW. Intra-articular hyaluronan (hyaluronic acid) and hylans for the treatment of osteoarthritis: mechanisms of action. Arthritis Res Ther. 2003;5(2):54–67. DOI: http://dx.doi.org/10.1186/ar623. Epub 2003 Jan 14.
5. Rinaudo M. Properties and degradation of selected polysaccharides. Corros Eng Sci Technol. 2007;(42):324–34. DOI: http://dx.doi.org/10.1179/174327807X238945.
6. Jordan KM, Arden NK, Doherty M. EULAR Recommendations, 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis. 2003 Dec;62(12):1145–55. DOI: http://dx.doi.org/10.1136/ard.2003.011742.
7. Hochberg MC, Altman RD, April KT; American College of Rheumatology. American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care Res (Hoboken). 2012;64(4):465–74. DOI: http://dx.doi.org/10.1002/acr.21596.
8. McAlindon TE, Bannuru RR, Sullivan MC. OARSI guidelines for the non-surgical management of knee osteoarthritis. Osteoarthritis Cartilage. 2014;22(3):363–88. DOI: 10.1016/j.joca.2014.01.003. Epub 2014 Jan 24.
9. Abate M, Salini V. Hyaluronic Acid in the Treatment of Osteoarthritis: What is New. In: Osteoarthritis-Diagnosis, Treatment and Surgery. InTech; 2012; 101–22. Available from: http://cdn.intechopen.com/pdfs/30684/InTech-yaluronic_acid_in_the_treatment_of_osteoarthritis_what_is_new.pdf
10. Cianflocco AJ. Viscosupplementation in patients with osteoarthritis of the knee. Postgrad Med. 2013;125(1):97–105. DOI: http://dx.doi.org/10.3810/pgm.2013.01.2618.
11. Bellamy N, Campbell J, Robinson V. Viscosupplementation for the treatment of osteoarthritis of the knee. Cochrane Database Syst Rev. 2006;19(2):CD005321.
12. Bannuru RR, Natov NS, Dasi UR. Therapeutic trajectory following intra-articular hyaluronic acid injection in knee osteoarthritis – meta-analysis. Osteoarthritis Cartilage. 2011;19(6):611–9. DOI: http://dx.doi.org/10.1016/j.joca.2010.09.014.
13. Huang TL, Chang CC, Lee CH, et al. Intra-articular injections of sodium hyaluronate (Hyalgan®) in osteoarthritis of the knee. A randomized, controlled, double-blind, multicenter trial in the Asian population. BMC Musculoskelet Disord. 2011;(12):221. DOI: 10.1186/1471-2474-12-221.
14. Беленький АГ, Денисов ЛН, Панасюк ЕЮ. Препарат гиалуроновой кислоты «Остенил» для лечения гонартроза. Результаты многоцентрового рандомизированного маскированного годичного исследования. Научно-практическая ревматология. 2005;(6):49–52. [Belen'kii AG, Denisov LN, Panasyuk EYu. Hyaluronic acid preparation «Ostenil» for treatment of a gonartroz. Results of the multicenter randomized masked year research. Nauchno-prakticheskaya revmatologiya = Rheumatology Science and Practice. 2005;(6):49–52. (In Russ.)]
15. Меньшикова ИВ, Маколкин ИЮ, Сугурова ИЮ. Применение препаратов гиалуроновой кислоты для локальной внутрисуставной терапии остеоартроза коленного сустава. Терапевтический архив. 2007;79(5):31–5. [Men'shikova IV, Makolkin IYu, Sugurova IYu. Hyaluronic acid drugs in local intra-ar-ticular therapy of knee joint osteoarthrosis. Terapevticheskii arkhiv. 2007;79(5):31–5. (In Russ.)]
16. Altman R. Criteria for classification of clinical osteoarthritis. J Rheumatol. 1991;22 Suppl 27:10–2.
17. Kellgren JH, Lawrence JS. Radiografhic assessment of osteoarthritis. Ann Rheum Dis. 1957;16(4):494–501. DOI: http://dx.doi.org/10.1136/ard.16.4.494.
18. Bellamy N, Buchanan WW, Goldsmith CH, et al. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol. 1988;15(12):1833–40.
19. Pham T, Heijde DVD, Lassere M. Outcome variables for osteoarthritis clinical trials: the OMERACT-OARSI set of responder criteria. J Rheumatol. 2003;30(7):1648–54.
20. Lee PB, Kim YC, Lim YJ. Comparison between high and low molecular weight hyaluronates in knee osteoarthritis patient: openlabel, randomized, multicentre clinical trial. J Int Med Res. 2006;34(1):77–87. DOI: http://dx.doi.org/10.1177/147323000603400110.
21. Михайлова АС, Теплякова ОВ, Соколова ЛА. Влияние локальной терапии гонартроза препаратами гиалуроновой кислоты различной молекулярной массы на динамику альгофункциональных индексов. Фарматека. 2011;(19):74–8. [Mikhailova AS, Teplyakova OV, Sokolova LA. Eeffect of local therapy of gonarthrosis by hyaluronic acid preparations of various molecular weights on dynamics of algofunctional measures. Farmateka. 2011;(19):74–8. (In Russ.)]
22. Moskowitz RW, Kelly MA, Lewallen DG. Understanding osteoarthritis of the knee-causes and effects. Am J Orthop (Belle Mead NJ). 2004;33(2 Suppl):5–9.
Review
For citations:
Vas'kova N.V., Lesnyak O.M. RUSVISK: DOMESTICALLY DEVELOPED PRODUCT OF HYALURONIC ACID: ASSESSMENT OF EFFICACY AND SAFETY IN EARLY STAGES OF THE KNEE OSTEOARTHRITIS. Rheumatology Science and Practice. 2014;52(5):538-544. (In Russ.) https://doi.org/10.14412/1995-4484-2014-538-544
Views:
3552
Email this article 